Report Feature
Cell Based Assay Market Trends and Forecast
The future of the global cell based assay market looks promising with opportunities in pharmaceutical & biopharmaceutical companies, CROs, and academic & research institutes. The global cell based assay market is expected to reach an estimated $32.3 billion by 2028 with a CAGR of 8.5% from 2023 to 2028. The major drivers for this market are increasing incidences of chronic diseases, increasing preference for cell-based assay, and rising investment in R&D of drug discovery activities.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Cell Based Assay Market by Segment
The study includes trends and forecast for the global cell based assay market by type, product & service, end user industry, and region, as follows:
Cell Based Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
-
Drug Discovery
- Toxicity Studies
- Pharmacodynamic Studies
- Pharmacokinetic Studies
- Basic Research
- Other Applications
Cell Based Assay Market by Product & Services [Value ($B) Shipment Analysis from 2017 to 2028]:
-
Consumables
- Reagents
-
Assay Kits
- Reporter Gene Assays
- Cell Growth Assays
- Second Messenger Assays
- Cell Death Assays
- Other Assay Kits
-
Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Microplates
- Probes & Labels
- Other Consumables
- Instruments & Software
- Services
Cell Based Assay Market by End User Industry [Value ($B) Shipment Analysis from 2017 to 2028
- Pharmaceutical & Biopharmaceutical Companies
- CROs
- Academic & Research Institutes
Cell Based Assay Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Cell Based Assays Companies
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, cell based assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the cell based assay companies profiled in this report include-
- Thermo Fisher Scientific
- Danaher Corporation
- Becton Dickinson
- GE Healthcare
- Merck KGaA
- Lonza Group
- PerkinElmer
- Charles River Laboratories
- Cell Signaling Technologies
- Cisbio
- Cell Biolabs
- Promega Corporation
Cell Based Assay Market Insights
- Lucintel forecasts that drug discovery segment is expected to witness the highest growth over the forecast period due to growing demand for novel therapeutic drugs to treat chronic diseases and increasing investment in research and development activities by the biopharmaceutical companies.
- Pharmaceutical and biopharmaceutical companies are expected to witness the highest growth over the forecast period due to increasing number of drug discovery projects and growing R&D expenditure by various biotech and pharma companies to develop drug candidates.
- APAC is expected to witness the highest growth over the forecast period due to the existence of private as well as government funding for research and development, rising demand for drug development, and increasing infrastructural development across the region.
Features of the Cell Based Assay Market
- Market Size Estimates: Cell based assay market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Cell based assay market size by various segments, such as type, product & service, end user industry, and region
- Regional Analysis: Cell based assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different types, type, product & service, end user industry, and regions for the cell based assay market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the cell based assay market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the cell based assay market size?
Answer: The global cell based assay market is expected to reach an estimated $32.3 billion by 2028.
Q2. What is the growth forecast for cell based assay market?
Answer: The global cell based assay market is expected to grow with a CAGR of 8.5% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the cell based assay market?
Answer: The major drivers for this market are increasing incidences of chronic diseases, increasing preference for cell-based assay, and rising investment in R&D of drug discovery activities.
Q4. What are the major segments for cell based assay market?
Answer: The future of the cell based assay market looks promising with opportunities in pharmaceutical & biopharmaceutical companies, CROs, and academic & research institutes.
Q5. Who are the key cells based assay companies?
Answer: Some of the key cell based assay companies are as follows:
Answer: The global cell based assay market is expected to reach an estimated $32.3 billion by 2028.
Q2. What is the growth forecast for cell based assay market?
Answer: The global cell based assay market is expected to grow with a CAGR of 8.5% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the cell based assay market?
Answer: The major drivers for this market are increasing incidences of chronic diseases, increasing preference for cell-based assay, and rising investment in R&D of drug discovery activities.
Q4. What are the major segments for cell based assay market?
Answer: The future of the cell based assay market looks promising with opportunities in pharmaceutical & biopharmaceutical companies, CROs, and academic & research institutes.
Q5. Who are the key cells based assay companies?
Answer: Some of the key cell based assay companies are as follows:
- Thermo Fisher Scientific
- Danaher Corporation
- Becton Dickinson and Company
- GE Healthcare
- Merck KGaA
- Lonza Group
- PerkinElmer
- Charles River Laboratories
- Cell Signaling Technologies
- Cisbio
- Cell Biolabs
- Promega Corporation
Q6. Which cell based assay segment will be the largest in future?
Answer: Lucintel forecasts that drug discovery segment is expected to witness the highest growth over the forecast period due to growing demand for novel therapeutic drugs to treat chronic diseases and increasing investment in research and development activities by the biopharmaceutical companies.
Q7. In cell based assay market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to the existence of private as well as government funding for research and development, rising demand for drug development, and increasing infrastructural development across the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that drug discovery segment is expected to witness the highest growth over the forecast period due to growing demand for novel therapeutic drugs to treat chronic diseases and increasing investment in research and development activities by the biopharmaceutical companies.
Q7. In cell based assay market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to the existence of private as well as government funding for research and development, rising demand for drug development, and increasing infrastructural development across the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
